AbstractImprovement in transduction efficiency makes it possible to convert blood cells into induced pluripotent stem cells (iPSC). In this study, we generated an iPSC line from peripheral blood mononuclear cells (PBMC) donated by a patient who exhibited memory deficit at age 59; outcome of positron emission tomography scan is consistent with a diagnosis of Alzheimer's disease. Integration-free CytoTune-iPS Sendai Reprogramming factors which include Sendai virus particles of the four Yamanaka factors Oct4, Sox2, Klf4, and c-Myc were introduced to PBMC to convert them to iPSCs without retention of virus. Three germ layer differentiation was induced to demonstrate the pluripotency of these iPSCs
A 76-year old Alzheimer's disease (AD) female patient donated her Peripheral blood mononuclear cells...
Peripheral blood mononuclear cells (PBMCs) were collected from a clinically characterised 75-year ol...
AbstractPeripheral blood mononuclear cells (PBMCs) were collected from a clinically characterised 57...
AbstractPeripheral blood mononuclear cells (PBMCs) were collected from a clinically characterised 75...
AbstractPeripheral blood mononuclear cells (PBMCs) were collected from a clinically characterised 84...
AbstractPeripheral blood mononuclear cells (PBMCs) were collected from a clinically characterised 57...
Abstract Peripheral blood mononuclear cells (PBMCs) derived from a healthy 40-year-old female were s...
AbstractInduced pluripotent stem cells (iPSCs) were generated from skin fibroblasts isolated from a ...
AbstractHere we describe the generation and characterization of the human induced pluripotent stem c...
AbstractSkin fibroblasts were obtained from a 46-year-old symptomatic man carrying a M146I mutation ...
A 87-year old Alzheimer's Disease(AD) male patient donated his Peripheral blood mononuclear cells (P...
Peripheral blood was collected from a clinically diagnosed 72-year old male patient with later onset...
AbstractPeripheral blood mononuclear cells (PBMCs) were collected from a clinically characterised, e...
AbstractPeripheral blood mononuclear cells (PBMC) were donated by a patient with clinically diagnose...
Peripheral blood mononuclear cells (PBMCs) were collected from a clinically characterised 57-year ol...
A 76-year old Alzheimer's disease (AD) female patient donated her Peripheral blood mononuclear cells...
Peripheral blood mononuclear cells (PBMCs) were collected from a clinically characterised 75-year ol...
AbstractPeripheral blood mononuclear cells (PBMCs) were collected from a clinically characterised 57...
AbstractPeripheral blood mononuclear cells (PBMCs) were collected from a clinically characterised 75...
AbstractPeripheral blood mononuclear cells (PBMCs) were collected from a clinically characterised 84...
AbstractPeripheral blood mononuclear cells (PBMCs) were collected from a clinically characterised 57...
Abstract Peripheral blood mononuclear cells (PBMCs) derived from a healthy 40-year-old female were s...
AbstractInduced pluripotent stem cells (iPSCs) were generated from skin fibroblasts isolated from a ...
AbstractHere we describe the generation and characterization of the human induced pluripotent stem c...
AbstractSkin fibroblasts were obtained from a 46-year-old symptomatic man carrying a M146I mutation ...
A 87-year old Alzheimer's Disease(AD) male patient donated his Peripheral blood mononuclear cells (P...
Peripheral blood was collected from a clinically diagnosed 72-year old male patient with later onset...
AbstractPeripheral blood mononuclear cells (PBMCs) were collected from a clinically characterised, e...
AbstractPeripheral blood mononuclear cells (PBMC) were donated by a patient with clinically diagnose...
Peripheral blood mononuclear cells (PBMCs) were collected from a clinically characterised 57-year ol...
A 76-year old Alzheimer's disease (AD) female patient donated her Peripheral blood mononuclear cells...
Peripheral blood mononuclear cells (PBMCs) were collected from a clinically characterised 75-year ol...
AbstractPeripheral blood mononuclear cells (PBMCs) were collected from a clinically characterised 57...